DCTN1 mutations in Perry syndrome
- PMID: 19136952
- PMCID: PMC2813485
- DOI: 10.1038/ng.293
DCTN1 mutations in Perry syndrome
Abstract
Perry syndrome consists of early-onset parkinsonism, depression, severe weight loss and hypoventilation, with brain pathology characterized by TDP-43 immunostaining. We carried out genome-wide linkage analysis and identified five disease-segregating mutations affecting the CAP-Gly domain of dynactin (encoded by DCTN1) in eight families with Perry syndrome; these mutations diminish microtubule binding and lead to intracytoplasmic inclusions. Our findings show that DCTN1 mutations, previously associated with motor neuron disease, can underlie the selective vulnerability of other neuronal populations in distinct neurodegenerative disorders.
Figures
Comment in
-
Dynactin mutations and promises for neurodegenerative pathology.Clin Genet. 2009 Jul;76(1):19-20. doi: 10.1111/j.1399-0004.2009.01231_1.x. Clin Genet. 2009. PMID: 19659757 No abstract available.
-
DCTN1 mutations are implicated in multiple neurodegenerative disorders.Clin Genet. 2010 Jan;77(1):32-4. doi: 10.1111/j.1399-0004.2009.01300.x. Clin Genet. 2010. PMID: 20101786 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
